Benefits
Modest Blood Pressure Reduction
Meta-analyses suggest aronia supplementation modestly reduces systolic blood pressure, particularly in individuals with mildly elevated baseline BP. Subgroup benefits appear at >50 mg/day anthocyanin doses, though overall evidence quality was rated very low to low.
LDL Cholesterol Reduction in Specific Populations
An RCT in former smokers showed aronia berry polyphenols reduced total and LDL cholesterol versus placebo. Subgroup analyses of pooled data suggest benefits primarily in individuals with baseline cholesterol <200 mg/dL — an unusual finding warranting more research.
Antioxidant Capacity
Aronia berries have among the highest measured ORAC (Oxygen Radical Absorbance Capacity) values of common foods. Anthocyanins and proanthocyanidins scavenge reactive oxygen species in vitro, though clinical translation to disease outcomes remains uncertain.
Endothelial Function Support
Smaller trials suggest aronia improves flow-mediated dilation (a marker of endothelial function) — possibly via NO-mediated vasodilation or polyphenol effects on vascular inflammation. Effect sizes are modest and replication is needed.
Possible Anti-Inflammatory Effects
Some trials report reductions in CRP or other inflammatory markers with aronia supplementation, though results are inconsistent across studies. Anti-inflammatory effects appear more pronounced in metabolically compromised populations.
Mechanism of action
Anthocyanin Antioxidant Activity
Aronia is exceptionally rich in cyanidin-3-galactoside and other anthocyanins, which directly scavenge free radicals and modulate redox-sensitive signaling pathways. They also induce endogenous antioxidant enzymes (catalase, glutathione peroxidase) via Nrf2 activation.
Endothelial Nitric Oxide Modulation
Polyphenols in aronia enhance endothelial nitric oxide synthase (eNOS) activity and protect NO from oxidative degradation, supporting vasodilation. This mechanism may underlie the modest BP-lowering effects observed in some trials.
Cholesterol Metabolism Effects
Proanthocyanidins inhibit cholesterol absorption and modulate hepatic LDL receptor expression. Aronia polyphenols also reduce oxidized LDL formation, which is more atherogenic than native LDL.
Anti-Inflammatory Signaling
Anthocyanins inhibit NF-κB signaling and reduce expression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β). They may also modulate the gut microbiome, with downstream anti-inflammatory effects.
Glycemic Modulation
Aronia extracts inhibit α-glucosidase and α-amylase enzymes, slowing carbohydrate digestion and reducing postprandial glucose spikes. Some trials show modest effects on fasting glucose and HbA1c, though others show no effect.
Clinical trials
Evidence review and pooled analysis of randomized controlled trials evaluating chokeberry supplementation on cardiometabolic outcomes. PRISMA-guided, searched through. (Frumuzachi, Mocan, Rohn, Gavrilaș 2025, Nutrients)
10 clinical trials (n=666 participants).
No significant effects on cardiometabolic outcomes in pooled analysis. Subgroup analyses suggested chokeberry could reduce total cholesterol and LDL-C in individuals with baseline TC <200 mg/dL, and reduce SBP with interventions providing >50 mg/day anthocyanin. Risk of bias was unclear or high in several studies. Grade certainty rated very low across all outcomes — more rigorous clinical trials needed.
Evidence review and pooled analysis of clinical trials evaluating aronia consumption on lipid profile, blood pressure, and inflammation markers. (Rahmani, Kamalinejad, Salari, Mirjalili, Eur J Nutr)
Multiple clinical trials reviewed; outcomes pooled by random-effects model.
Aronia consumption was associated with reductions in total cholesterol, LDL-C, and CRP. Effects on blood pressure and triglycerides were less consistent. Evidence quality varied across studies; effect sizes were modest.
Randomized controlled trial of aronia berry polyphenol consumption on plasma cholesterol, inflammation, and oxidative stress markers in former smokers. (Xie, Vance, Kim et al. 2017, Nutrition Research)
Former smokers; randomized to aronia polyphenol intervention vs. control for 12 weeks.
Aronia berry polyphenol consumption significantly reduced plasma total cholesterol and LDL cholesterol vs. control. However, no significant changes in inflammation biomarkers (CRP, IL-6) or oxidative stress markers were observed.